Fulgent Genetics
FLGT
141 hedge funds and large institutions have $322M invested in Fulgent Genetics in 2026 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 55 reducing their positions, and 36 closing their positions.
1,014% more call options, than puts
Call options by funds: $3M | Put options by funds: $269K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.68% less ownership
Funds ownership: 55.92% → 55.24% (-0.68%)
11% less funds holding
Funds holding: 158 → 141 (-17)
27% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 55
39% less capital inflows, than outflows
Capital inflows: $43.9M | Capital outflows: $72M
44% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$7.22M |
| 2 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$5.71M |
| 3 |
JP Morgan Chase
New York
|
+$5.02M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.59M |
| 5 |
HRT Financial
New York
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RTW Investments
New York
|
-$20.5M |
| 2 |
BlackRock
New York
|
-$8.27M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.06M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.66M |
| 5 |
D.E. Shaw & Co
New York
|
-$3.3M |
FLGT Hedge Fund Activity: Q2 2026 in Review
141 of the 8,355 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2026, worth a combined $322M — up 16% from $278M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of FLGT and 20 opened new positions — a net loss of 16 holders — while 55 trimmed existing stakes and 40 added.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $7.22M. The largest seller was RTW Investments, exiting entirely with an estimated $20.5M sold.
- 141 institutional investors held Fulgent Genetics (FLGT) as of Q2 2026, down from 158 in Q1 2026.
- Funds reported $322M of Fulgent Genetics stock for Q2 2026, up 16% quarter-over-quarter.
- 20 funds opened new Fulgent Genetics positions in Q2 2026 and 36 closed out, a net change of -16 holders.
- The largest Fulgent Genetics buyer in Q2 2026 was Jacobs Levy Equity Management, an estimated $7.22M added.
- The largest Fulgent Genetics seller in Q2 2026 was RTW Investments, an estimated $20.5M sold.
Based on aggregated 13F filings for Q2 2026.